UFP Technologies functions as a contract development and manufacturing organization, focusing on single-use and single-patient medical devices and sterile packaging. The company positions itself as a critical component within the medical device supply chain, serving as an outsourced partner to major global manufacturers. Its products are integral to a spectrum of medical applications, including minimally invasive surgery, infection prevention, wound care, wearables, and orthopedic implants.
Expanding Reach and Capabilities
The company has actively pursued a strategy of global expansion and capability enhancement. Notably, UFP Technologies acquired AQF Medical, based in Navan, Ireland, which specializes in custom-engineered foam and thermoplastic components for medical devices and packaging. This move bolsters UFP's European manufacturing presence and its 'medtech' platform.
Recent acquisitions also include AJR Enterprises for single-use patient handling systems, Welch Fluorocarbon Inc. for thin-film thermoforming for implantable devices, and Marble Medical for adhesive-based components and single-use devices.
A joint venture facility in Singapore aims to provide local support for the Asian market.
Operational and Financial Snapshot
UFP Technologies, listed on NASDAQ (UFPT), reported strong first-quarter results. Financially, as of recent data:
| Metric | Value |
|---|---|
| Market Cap | $1.64B |
| Revenue (TTM) | $608.85M |
| Net Income (TTM) | $68.62M |
| EPS (TTM) | $8.81 |
| P/E Ratio | 24.12 |
| Dividend | $0.00 |
| Beta (Volatility) | 0.94 |
In its latest reported quarterly performance:
Read More: Ted Turner, CNN Founder, Dies at 87 in Florida
Revenue reached $154.20M, a 4.1% increase.
Gross Profit stood at $44.36M, up 5.2%, with a Gross Margin of 28.77%.
Net Income was $17.50M, a 1.8% increase.
However, EBITDA saw a -15.7% decrease to $23.37M.
Net Cash increased by 36.2% to $117.63M.
Conversely, Short Term Debt surged by 727.7% to $137.61M.
Free Cash Flow experienced a -39.5% decline to $12.96M.
Operating Cash Flow also dropped by -31.1% to $16.84M.
The company's overall financial health indicators, including Margins and Returns, show a consistent performance, though certain cash flow metrics have recently trended downwards.
Company Background and Focus
UFP Technologies operates as a full-service partner, involved in the design, development, engineering, and manufacturing of custom products. While its primary focus is on medical devices and sterile packaging, it also caters to sectors such as aerospace, defense, and automotive with highly engineered components. The company emphasizes its comprehensive solutions, extensive engineering expertise, and a global manufacturing footprint designed to expedite product market entry.
The 'UFP MedTech' division specifically highlights its role in accelerating the development and production of single-use devices and sterile packaging. Its solutions are crafted from medical-grade materials compatible with various sterilization methods, and the company touts expertise in advanced materials for infection control and prevention, aiming to minimize hospital-acquired infections and enhance patient safety. Its single-use devices for interventional and surgical procedures are positioned to contribute to reduced patient pain, shorter hospital stays, and fewer complications.
Read More: NJ Tax Credit for Local Brands Amidst Political Debate
